PANCAR
LIVE

Serial Number

98342248

Owner

Orna Therapeutics, Inc.

Attorney

Jonathan M. Gelchinsky

Filing Date

Jan 4, 2024

Add to watchlist:

No watchlists yet
View on USPTO

PANCAR Trademark

Serial Number: 98342248

PANCAR is a trademark filed by Orna Therapeutics, Inc. on January 4, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Orna Therapeutics, Inc.

500 Forge Road
Watertown, MA 02472

Entity Type: 03

Trademark Details

Filing Date

January 4, 2024

Registration Date

Not Registered

Published for Opposition

September 3, 2024

Goods & Services

Pharmaceutical preparations for the treatment and prevention of autoimmune, immune mediated, and inflammatory diseases and disorders, nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics for the treatment and prevention of autoimmune, immune mediated, and inflammatory diseases and disorders; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical products for the prevention and treatment of cancer; therapeutic vaccines; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for the treatment of immune system related diseases and disorders; therapeutic pharmaceutical for the treatment of autoimmune, immune mediated, and inflammatory diseases and disorders, nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics for the treatment and prevention of autoimmune, immune mediated, and inflammatory diseases and disorders

Medical services

Medical and scientific research in the field of nucleic acid pharmaceuticals, medicine, biologics, biotherapeutics, biosimilars and therapeutics

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 2, 2026 EXRA
SOU EXTENSION 3 GRANTED
Mar 31, 2026 EX3G
SOU EXTENSION 3 FILED
Mar 31, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 31, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 24, 2025 EXRA
SOU EXTENSION 2 GRANTED
Oct 23, 2025 EX2G
SOU EXTENSION 2 FILED
Oct 23, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 23, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 4, 2025 EXRA
SOU EXTENSION 1 GRANTED
Apr 4, 2025 EX1G
SOU EXTENSION 1 FILED
Apr 3, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 3, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 29, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 3, 2024 NPUB
PUBLISHED FOR OPPOSITION
Sep 3, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 14, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 1, 2024 CNSA
ASSIGNED TO EXAMINER
Aug 1, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 22, 2024 NWOS
NEW APPLICATION ENTERED
Jan 4, 2024 NWAP